Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07693036

hUC-MSC-Exosomes for T2DM - Safety & Efficacy

Conditions: Type 2 Diabetes Mellitus (T2DM)

Sex: All

Ages: 18 Years – 65 Years

Healthy volunteers: No

Phase: PHASE1, PHASE2

Enrollment: 66

Sponsor: Peking University First Hospital

Location: Peking University first Hospital Beijing

Summary

The goal of this clinical trial is to Evaluate the Safety and Preliminary Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Adult Type 2 Diabetes Mellitus.

Eligibility Criteria

Inclusion Criteria: 1. Age 18-65 years, diagnosed with T2DM for ≥5 years (\

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07693036). StuddyBuddy aggregates publicly available trial information.